Designing Your Protocol: Dosing and Timing Protocol design requires balancing effectiveness against manageability
NICE guidance on obesity (CG189: Obesity: identification, assessment and management) and lifestyle weight management services (PH53) emphasises structured lifestyle interventions, behavioural support, and where clinically appropriate pharmacological treatment prescribed by a clinician, rather than over-the-counter supplements
This may involve reviewing lab results and identifying any additional health considerations
What it can do, when taken correctly and consistently, is support your body from the inside in ways that matter, from antioxidant protection to skin health to overall wellness
Important context: While worsening heart failure events were meaningfully reduced, cardiovascular deaths were numerically higher in the tirzepatide group at 2.2% versus 1.4% in the placebo group